Stifel Maintains Hold on Macrogenics, Lowers Price Target to $5
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Stephen Willey maintains Macrogenics (NASDAQ:MGNX) with a Hold and lowers the price target from $6 to $5.
Stifel analyst Stephen Willey maintains Macrogenics (NASDAQ:MGNX) with a Hold and lowers the price target from $6 to $5.